» Articles » PMID: 34790228

Human Organoids for Predictive Toxicology Research and Drug Development

Overview
Journal Front Genet
Date 2021 Nov 18
PMID 34790228
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

Organoids are three-dimensional structures fabricated in vitro from pluripotent stem cells or adult tissue stem cells a process of self-organization that results in the formation of organ-specific cell types. Human organoids are expected to mimic complex microenvironments and many of the physiological functions of relevant tissues, thus filling the translational gap between animals and humans and increasing our understanding of the mechanisms underlying disease and developmental processes. In the last decade, organoid research has attracted increasing attention in areas such as disease modeling, drug development, regenerative medicine, toxicology research, and personalized medicine. In particular, in the field of toxicology, where there are various traditional models, human organoids are expected to blaze a new path in future research by overcoming the current limitations, such as those related to differences in drug responses among species. Here, we discuss the potential usefulness, limitations, and future prospects of human liver, heart, kidney, gut, and brain organoids from the viewpoints of predictive toxicology research and drug development, providing cutting edge information on their fabrication methods and functional characteristics.

Citing Articles

Current Treatment Regimens and Promising Molecular Therapies for Chronic Hepatobiliary Diseases.

Durazzo M, Ferro A, Navarro-Tableros V, Gaido A, Fornengo P, Altruda F Biomolecules. 2025; 15(1).

PMID: 39858515 PMC: 11763965. DOI: 10.3390/biom15010121.


Model Organoids: Integrated Frameworks for the Next Frontier of Healthcare Advancements.

Bhattacharya R, Bose D, Kaur T, Patel R, Renuka O, Rodriguez R Stem Cell Rev Rep. 2024; 21(2):319-336.

PMID: 39527389 DOI: 10.1007/s12015-024-10814-3.


Organoid intelligence for developmental neurotoxicity testing.

Alam El Din D, Shin J, Lysinger A, Roos M, Johnson E, Shafer T Front Cell Neurosci. 2024; 18:1480845.

PMID: 39440004 PMC: 11493634. DOI: 10.3389/fncel.2024.1480845.


Challenges in validation of combination treatment strategies for CRC using patient-derived organoids.

Benboubker V, Ramzy G, Jacobs S, Nowak-Sliwinska P J Exp Clin Cancer Res. 2024; 43(1):259.

PMID: 39261955 PMC: 11389238. DOI: 10.1186/s13046-024-03173-x.


Biodegradation of hydroxylated boron nitride nanoplatelets, their toxic effect and drug delivery application.

Asif K, Rahman M, Sfriso A, Parisi S, Canzonieri V, Caligiuri I RSC Adv. 2024; 14(36):26568-26579.

PMID: 39175687 PMC: 11339772. DOI: 10.1039/d4ra04433a.


References
1.
Reuben A, Koch D, Lee W . Drug-induced acute liver failure: results of a U.S. multicenter, prospective study. Hepatology. 2010; 52(6):2065-76. PMC: 3992250. DOI: 10.1002/hep.23937. View

2.
Schwartz R, Fleming H, Khetani S, Bhatia S . Pluripotent stem cell-derived hepatocyte-like cells. Biotechnol Adv. 2014; 32(2):504-13. PMC: 4043206. DOI: 10.1016/j.biotechadv.2014.01.003. View

3.
Bartfeld S, Clevers H . Stem cell-derived organoids and their application for medical research and patient treatment. J Mol Med (Berl). 2017; 95(7):729-738. DOI: 10.1007/s00109-017-1531-7. View

4.
Patel N, Birla R . The Bioengineered Cardiac Left Ventricle. ASAIO J. 2017; 64(1):56-62. DOI: 10.1097/MAT.0000000000000642. View

5.
Morizane R, Lam A, Freedman B, Kishi S, Valerius M, Bonventre J . Nephron organoids derived from human pluripotent stem cells model kidney development and injury. Nat Biotechnol. 2015; 33(11):1193-200. PMC: 4747858. DOI: 10.1038/nbt.3392. View